Frontline Plc Ordinary Shares vs Halozyme Therapeutics Inc. Common Stock — how do they compare? Frontline Plc Ordinary Shares trades at $56.26 (market cap $12.52B), while Halozyme Therapeutics Inc. Common Stock trades at $111.18 (market cap $12.58B). The key difference: Frontline Plc Ordinary Shares and Halozyme Therapeutics Inc. Common Stock are close in size by market cap, and Frontline Plc Ordinary Shares pays a 9.56% dividend while Halozyme Therapeutics Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Frontline Plc Ordinary Shares for 0 Days and Halozyme Therapeutics Inc. Common Stock for 0 Days on average.
| FRO | HALO | |
|---|---|---|
Market Cap | $12.52B | $12.58B |
Volume | 6,375,509 | 2,179,278 |
Sector | Industrials | Health |
52-Week High | $56.26 | $115.22 |
52-Week Low | $20.58 | $61.63 |
Typical Hold Time | 0 Days | 0 Days |
Enterprise Value | $14.64B | $14.49B |
Dividend Yield | 9.56% | — |
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Frontline operates a fleet of oil tankers that transport crude oil by sea. Its vessels serve global energy trading routes.
Read more on FRO →Halozyme Therapeutics develops drug-delivery technologies for biopharmaceutical companies. Its ENHANZE technology uses the rHuPH20 enzyme to support subcutaneous delivery of co-administered medicines.
Read more on HALO →